Stock Market Today: Dow 30,000 in Sight After Another Vaccine Rally
Moderna (MRNA) followed up last week's Pfizer (PFE) act with outstanding vaccine data of its own, pushing the Dow to new highs just 50 points shy of 30,000.
- (opens in new tab)
- (opens in new tab)
- (opens in new tab)
- Newsletter sign up Newsletter

Don't dismiss that feeling of déjà vu. Today's market action was absolutely similar to last Monday's vaccine-fueled rally. This time, however, it wasn't Pfizer (PFE (opens in new tab)) and BioNTech (BNTX (opens in new tab)), but Moderna (MRNA (opens in new tab), +9.6%) releasing good news about its trial candidate.
Early data suggests Moderna's mRNA-1273 vaccine is 94.5% effective, which Dr. Anthony Fauci, the nation's top infectious-diseases official, called "truly outstanding."
Better still, Moderna's vaccine can be stored for 30 days between 36 to 46 degree Fahrenheit (about what you'd find in a refrigerator), and for six months at -4 degrees. That's much more forgiving for storage and transportation purposes than Pfizer's vaccine, which must be kept at -94 degrees.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"Last week’s Pfizer news was great, but today's Moderna vaccine news is even better," says Ryan Detrick, chief market strategist for LPL Financial. "Being able to store the vaccine in a standard fridge for up to a month makes transportation and usability so much easier. Yes, new cases and hospitalizations are soaring, but we are inching closer to ending this pandemic."
And just like last week, investors gobbled up airlines, cruise lines and other COVID-battered stocks whose fates are tethered to vaccine success. The Dow Jones Industrial Average jumped 1.6% to a new high of 29,950, lifted by big gains from industrial stocks such as Boeing (BA (opens in new tab), +8.2%) and Honeywell (HON (opens in new tab), +3.5%).
Other action in the stock market today:
- The S&P 500 also hit a new high, gaining 1.2% to 3,626.
- The small-cap Russell 2000 rewrote the record books, soaring 2.4% to 1,785.
- Once again, the tech-heavy Nasdaq Composite lagged the group, finishing up 0.8% to 11,924.
How to Play This Rotation
Wall Street's pros continue to have faith in a continued rotation out of 2020's early winners and into the market's more battered (but recovering) names.
"The path of least resistance for equities seems to be higher at the moment as favorable vaccine news, along with less uncertainty regarding the election, is proving to be a positive catalyst in the near term," says Brian Price, Head of Investment Management for Commonwealth Financial Network. "It's encouraging that we're seeing a rotation from growth and momentum-oriented stocks to value and cyclical names."
We've previously highlighted ways to invest in value now -- stock investors can target these seven picks, while those who prefer funds can explore these seven options. You can leverage this movement in other ways, too, such as sector investing -- among these 16 sector funds are products that provide exposure to industrials, financials and other recovery-sensitive plays.
Another area of the market to watch is the biotechnology space. Yes, this contains companies involved in developing COVID vaccines and treatments, but in general, many healthcare plays should also get a boost when the pandemic recedes and providers can resume regular treatments.
Read on as we look at 14 biotech and biopharmaceutical stocks that look attractive as 2020 winds down and 2021 nears. This list includes Big Pharma firms that are adding biotech exposure, biotech-industry leaders and smaller biotechnology firms that are trying to catch their big break.
Kyle Woodley was long BA as of this writing.
Kyle Woodley is the Editor-in-Chief of Young and The Invested (opens in new tab), a site dedicated to improving the personal finances and financial literacy of parents and children. He also writes the weekly The Weekend Tea (opens in new tab) newsletter, which covers both news and analysis about spending, saving, investing, the economy and more.
Kyle was previously the Senior Investing Editor for Kiplinger.com, and the Managing Editor for InvestorPlace.com before that. His work has appeared in several outlets, including Yahoo! Finance, MSN Money, Barchart, The Globe & Mail and the Nasdaq. He also has appeared as a guest on Fox Business Network and Money Radio, among other shows and podcasts, and he has been quoted in several outlets, including MarketWatch, Vice and Univision. He is a proud graduate of The Ohio State University, where he earned a BA in journalism.
You can check out his thoughts on the markets (and more) at @KyleWoodley (opens in new tab).
-
-
Best 5-Year CD Rates for March 2023 as Rates Rise
Here are the best 5-year CD rates as the Fed continues its campaign to raise interest rates to try to combat inflation.
By Erin Bendig • Published
-
Stock Market Today: Stocks Sink After Latest Fed Rate Hike
The major indexes sold off sharply Wednesday even amid signs the Fed's rate-hike campaign could be nearing an end.
By Karee Venema • Published
-
Stock Market Today: Stocks Sink After Latest Fed Rate Hike
The major indexes sold off sharply Wednesday even amid signs the Fed's rate-hike campaign could be nearing an end.
By Karee Venema • Published
-
Stock Market Today: Markets Up Again as Bank, Energy Stocks Outperform
The major indexes closed higher for a second straight day ahead of tomorrow's highly anticipated Fed decision.
By Karee Venema • Published
-
Stock Market Today: Stocks Rise Ahead of Fed
Bank headlines dominated another choppy day of trading on Wall Street.
By Karee Venema • Published
-
Stock Market Today: Stocks Fall After First Republic Bank Suspends Dividend
The embattled lender's dividend cut was just the latest sign of instability in the banking industry.
By Karee Venema • Published
-
Stock Market Today: Stocks Rally on Credit Suisse, First Republic Bank Rescue News
Reports that major U.S. banks would step in to help First Republic Bank helped stocks swing higher Thursday.
By Karee Venema • Published
-
If You'd Put $1,000 Into Netflix Stock 20 Years Ago, Here's What You'd Have Today
Netflix Netflix stock is down almost 60% from its all-time closing high, but it's still a big-time market beater.
By Dan Burrows • Published
-
Stock Market Today: Stocks Struggle on Credit Suisse, First Republic Bank Concerns
Chaos in the financial sector stole the spotlight from this morning's inflation and retail sales updates.
By Karee Venema • Published
-
Stock Market Today: Markets Rise as Bank Stocks Bounce
Investors also focused on the February CPI report, which gave a mixed picture on inflation.
By Karee Venema • Published